Pendahuluan. Penyait Ginjal Stadium Akhir (end stage renal disease, ESRD) merupakan stadium Penyakit Ginjal Kronis (PGK) yang memerlukan terapi pengganti ginjal termasuk hemodialisis (HD). Indikator keberhasilan HD termasuk kinerja jantung dan kualitas hidup pasien diyakini tergantung pada indikator proses yang meliputi kecukupan (adekuasi) HD, kejadian anemia serta malfungsi akses vaskular dan infeksi. Tujuan. Penelitian ini bertujuan untuk menilai hubungan antara indikator proses dan indikator hasil pasien HD. Metode. Penelitian ini merupakan penelitian observasional analitik dengan pendekatan kohort yang melibatkan 350 pasien dari 5 unit HD di Provinsi Aceh. Data diperoleh dari rekam medis pasien, sedangkan kualitas hidup pasien HD dinilai dengan kuesioner Kidney Disease Quality of Life (KDQoL). Kinerja jantung dinilai dengan menggunakan ekokardiografi. Hasil. Hasil penelitian menunjukkan adanya hubungan positif yang signifikan antara hemoglobin (Hb) dan adekuasi HD dengan fraksi ejeksi pasien yang menjalani HD. Selain itu, penelitian ini juga menemukan hubungan positif yang signifikan antara Hb dan adekuasi dengan kualitas hidup pasien HD, terutama fungsi fisik dan kesejahteraan emosional. Kesimpulan. Adanya korelasi positif antara Hb dan adekuasi HD dengan kinerja jantung dan kualitas hidup menunjukkan pentingnya indikator proses dalam meningkatkan kualitas pelayanan HD serta pasien HD.
Background:The world is facing a global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Kidney transplant recipients at increased risk for COVID-19 infection due to prolonged use of immunosuppressants. Recommendations have been made by different countries for prevention and contingency against COVID-19 in kidney patients, including kidney transplant patients. Case report: A 60-year-old male was admitted with dyspnea, fever, and cough. The result of thorax rontgen showed bronchopneumonia, meanwhile his renal ultrasound showed chronic pyelonephritis. Laboratory result was hemoglobin 8.1 g/dL, blood sugar 286 g/dL, D-dimer 800 ng/mL, blood urea nitrogen 123 mg/dL, creatinine 4.8 mg/dL. He has history of diabetic and kidney transplant 14 years ago. He was genetically confirmed as COVID-19 by swab polymerase chain reaction (PCR) testing. The patient was confirmed to the diagnosis of severe case of COVID-19, chronic rejected allograft kidney transplant with comorbid disease of stage II hypertension, diabetes, pneumonia and anemia. During hospitalization, remdesivir therapy 200 mg IV per 12 hours, heparin 5,000 units per 8 hours, meropenem 1 g per 12 hours, and methylprednisolone 20 mg per day was given, while other immunosuppressant were being hold. After 10 days of hospitalization, clinical condition improved and PCR test converted negative then immunosuppressant were being continued, dialysis therapy has not been done because urine output is still good. Conclusions: Reduction immunosuppression to maintain host defense mechanisms is problematic, especially in patients with immune-mediated kidney disease, disease relapse or transplant rejection. ERA-EDTA DESCARTES expert opinion suggests reducing or stopping AZA/MPA/mTORi (if on triple therapy) for asymptomatic COVID-19 patients and discontinue all immunosuppressive drugs and increase or start steroids for more severe transplant patients with COVID-19.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.